The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation-Reference-Cited by-同舟云学术

The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation

Published:2024-04 Issue:4 Volume:27 Page:500-507
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Szafranski Kirk,De Pouvourville Gerard,Greenberg Dan,Harris Stewart,Jendle Johan,Shaw Jonathan E.,Castro JeanPierre Coaquira,Poon Yeesha,Levrat-Guillen Fleur

Funder

Abbott Diabetes Care

Publisher

Elsevier BV

Reference37 articles.

1. Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the Ninth Mount Hood Diabetes Challenge;Si;Value Health,2020

2. Cost effectiveness analysis of a flash glucose monitoring system for type 1 diabetes (T1DM) patients receiving intensive insulin treatment in Europe and Australia;Bilir;Value Health,2016

3. Cost-effectiveness analysis of a flash glucose monitoring system for patients with Type 1 diabetes receiving intensive insulin treatment in Sweden;Bilir;Eur Endocrinol,2018

4. Cost-effectiveness of the FreeStyle Libre((R)) system versus blood glucose self-monitoring in individuals with type 2 diabetes on insulin treatment in Sweden;Jendle;Diabetes Ther,2021

5. Cost effectiveness analysis of a flash glucose monitoring system for type 2 diabetes (T2DM) patients receiving intensive insulin treatment in Europe;Li;Value Health,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to Medicaid;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective;Diabetes, Obesity and Metabolism;2024-06-10